ARTICLE | Company News
Microbiotix, Merck deal
January 7, 2013 8:00 AM UTC
Microbiotix Inc., Worcester, Mass. Merck & Co. Inc. (NYSE:MRK), Whitehouse Station, N.J. Business: Infectious Merck granted Microbiotix exclusive, worldwide rights to two non-nucleoside HCV NS5B inhi...